SOURCENTRL logo

Source Natural Foods & Herbal Supplements Ltd

SOURCENTRL·BSE·
₹109.00▼ -3.85 (-3.41%)
Market Cap70.16 Cr
PE Ratio19.33
Volume447
Day High - Low115.00 - 105.00
52W High-Low155.90 - 96.55

Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL): company summary

The company's business has grown significantly, with annual revenue rising 56.7% year-over-year to ₹70 crore and annual net profit increasing 25.9% to ₹4 crore.

Source Natural Foods & Herbal Supplements Ltd (SOURCENTRL) is a micro-cap Healthcare company valued at ₹70 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Source Natural Foods & Herbal Supplements Ltd last traded at ₹109, down 3.41% on the day.
Financial performance
The company's business has grown significantly, with annual revenue rising 56.7% year-over-year to ₹70 crore and annual net profit increasing 25.9% to ₹4 crore. However, the net profit margin narrowed 1.3 percentage points to 5.2%, while return on equity and return on capital employed remained stable at 14.2% and 16.6%, respectively.
Valuation multiples
The stock trades at 19.3 times earnings, a discount to the Healthcare median of 32.0, 9.25 times book value.
Things to watch
The stock is 27.6% below its 52-week high, and the net profit margin has declined, which could affect profitability. The company's market cap is ₹73 crore, indicating it is a micro-cap stock with limited liquidity.
Where it stands
The company has shown strong revenue growth over the past three years, with a 52.6% annualized increase, but its net profit margin has declined. The stock is currently 27.6% below its 52-week high, and the latest quarter's net profit was flat compared to the same quarter a year earlier.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
4.1/10
Weak
Fair Value
Sign in to see
ROE
14.16%
Average
P/E
19.33x
Fair
Debt / Equity
0.30
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Weak

Price performance

Day₹105.00
₹115.00
52W₹96.55
₹155.90
DocStoX take

Supported by risk (7.0), but held back by momentum (0.9).

DocStoX score

Low confidence
4.1
/10
Weak
Quality
Modest
ROE 14.2%
Valuation
Rich
P/E 19.3×
Growth
Slow
Revenue +23.1% 5Y CAGR
Risk
Moderate
D/E 0.30
Momentum
Weak
21% of 52-week range

At a glance

Market Cap
₹70 Cr
52W High / Low
₹156 / ₹97
Dividend Yield
0.00%
Promoter Holding
74.37%
EPS (TTM)
₹5.64
Book Value
₹40.01

Key highlights

  • Profitable in all of the last 5 years
  • Revenue compounding 23% a year
  • Momentum is weak (0.9/10)
  • Near the bottom of its 52-week range (21%)
2 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Source Natural Foods & Herbal Supplements Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.